Articles with keyword chemotherapy

Metronomic chemotherapy: efficacy in real clinical practice (V.A. Chubenko, L.A. Zagorskaya, V.S. Chubenko, F.V. Moiseenko, N.Kh. Abduloeva, A.S. Zhabina, M.M. Kramchaninov, K.V. Shelekhova, A.A. Meldo, E.M. Zykov, A.A. Kudryavcev, E.V. Napolskaya, V.M. Moiseyenko)

metronomic chemotherapy, stable disease, time to progression, toxicity.

Intraperitoneal chemotherapy in patients with advanced ovarian cancer: phase 2 institutional study (A.S. Tyulyandina, V.М. Nechushkina, L.V. Cherkes, K.Y. Morkhov, A.A. Rumyantsev, I.A. Pokataev, E.V. Glazkova, E.R. Virshke, D.Y. Frantsev, K.I. Zhordania, Y.V. Bujdenok, R.K. Valiev, A.V. Petrovsky, Y.S. Sergeev, I.V. Panichenko, A.A. Bulanov, M.B. Stenina, S.A. Tyulyandin)

ovarian cancer, intraperitoneal chemotherapy, intravenous chemotherapy, optimal cytoreduction, cisplatin, paclitaxel.

OLANZAPINE VERSUS APREPITANT IN PATIENTS RECEIVING HIGH-EMETOGENIC CHEMOTHERAPY: INTERIM ANALYSIS OF RANDOMIZED PHASE II TRIAL (A.A. Rumyantsev, E.V. Glazkova, R.Yu. Nasyrova, E.O. Ignatova, L.V. Chitia, A.S. Popova, Kh.Kh. Elsnukaeva, I.A. Pokataev, A.S. Tyulyandina, M.B. Stenina, M.A. Frolova, A.A. Bulanov, V.Yu. Fedyanin, O.V. Sekhina, A.A. Tryakin, S.A. Tjulandin)

olanzapine, aprepitant, chemotherapy, supportive care, CINV, nausea, vomiting.

First line dosointensive chemotherapy for Disseminated ovarian cancer after non optimal Cyted reduction: Results of the phase ii study (A.A. Rumyantsev, A.S. Tyulyandina, I.A. Pokataev, K.Yu. Morkhov, V.M. Nechushkina, V.E. Nikulin, S.O. Nikogosyan, K.I. Zhordania, S.A. Tyulyandin)

ovarian cancer, dose-dense chemotherapy, dose-intensive chemotherapy, suboptimal debulking, non-optimal debulking.

Long-lasting full remission after selective intra-arterial chemotherapy for recurrence of locally advanced oral mucosa carcinoma (I.P. Moshurov, A.N. Redkin, N.A. Znatkova, M.S. Olshansky, A.Yu. Shklyarov, A.V. Tsurikova, S.A. Stikina)

squamous cell carcinoma of the head and neck, relapse of oral cavity cancer, chemoradiation, intra-arterial chemotherapy, chemoembolization.

FIFTEEN COURSES OF SELECTIVE INTRA-ARTERIAL CHEMOTHERAPY FOR RELAPSE OF CANCER OF THE ORAL MUCOSA IN ONE PATIENT (M.S. Olshansky, A.Yu. Shklyarov, Yu.S. Konstantinova, E.N. Suhochev, S.A. Stikina, A.N. Redkin)

squamous cell carcinoma of the head and neck, relapse of oral cavity cancer, chemoradiation treatment, intraarterial chemotherapy.

What has changed in clinical oncology practice In 2019? (M.Y. Fedyanin)

cancer, chemotherapy, immunotherapy, targeted therapy.

NEW APPROACHES TO ADJUVANT THERAPY OF MALIGNANT TUMORS (K.S. Titov, A.V. Krasnorutsky, A.M. Kazakov, D.A. Ryabchikov)

adjuvant chemotherapy, breast cancer, colorectal cancer, melanoma, sarcoma.

Pending issues of standard approaches in oncology (A.A. Tryakin, M.Yu. Fedyanin, I.A. Pokataev, A.V. Petrovsky)

clinical guidelines, standards of care, chemotherapy, oncology.

MEDICAL ERRORS IN THE DIAGNOSIS AND TREATMENT OF MALIGNANT TROPHOBLASTIC TUMORS (Z.A. Gasanbekova, L.A. Meshcheryakova, S.A. Aliev, V.V. Kuznetsov)

trophoblastic, tumors, choriocarcinoma, bladder skeleton, chorionic gonadotropin, chemotherapy.

BIOPSY OF THE LYMPH NODES IN BREAST CANCER (E.M. Bit-Sava, M.G. Anchabandze, M.A. Monogarova, V.M. Moiseyenko)

biopsy of signaling lymph nodes, axillary lymphadenectomy, neoadjuvant chemotherapy.

MEDICAL TREATMENT OF TUMORS: WHAT NEED TO KNOW A PRAC TICAL ONCOLOGIST (V.A. Chubenko)

chemotherapy, immunotherapy, target therapy, overall survival, treatment guidelines.

Debulking surgery in oncogynecology (S.Ya. Maximov, I.V. Sobolev, A.S. Hadjimba, A.A. Ilin, E.D. Gershfeld, D.-K. Reyes Santiago)

cytoreductive, debulking surgery, ovarian cancer, cervical cancer, endometrial cancer, chemotherapy, radiotherapy

Clinical management of peritoneal metastases from colorectal cancer (D. Baratti, Sh. Kusamura, M. Guaglio, M. Deraco)

colorectal cancer, peritoneal metastasis, cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, HIPEC, liver metastasis

PROMISING METHODS FOR THE TREATMENT OF METASTATIC BREAST CANCER (A.S. Zhabina)

metastatic breast cancer, high-dose chemotherapy, metronome therapy, vaccine therapy, adoptive therapy.

RE-IRRADIATION THERAPY FOR RECURRENT BRAIN TUMORS (O.I. Shcherbenko, O.S. Regentova)

brain tumors, relapses, radiation therapy, chemotherapy, medulloblastoma, ependymoma, glioma, brain stem tumor, radiation injuries.

Practical and theoretical issues of surgery in oncology (V.V. Egorenkov)

surgical oncology, minimally invasive surgery, sentinel node biopsy, cytoreductive surgery, intraoperative chemotherapy, reconstructive surgery.

CHANGES IN NEO- AND ADJUVANT TREATMENT OF BREAST CANCER IN THE LAST 5 YEARS (M.B. Stenina, M.A. Frolova, D.Z. Kupchan, S.A. Tjulandin)

early breast cancer, neo-adjuvant therapy, adjuvant therapy, radiotherapy, chemotherapy, hormonotherapy, anti-HER2 therapy, ovarian suppression.

Surgical decision making in treating patients with metastatic tumors. focus on surgical treatment of peritoneal carcinomatosis (O.E. Kalinin, V.V. Gushchin)

peritoneal carcinomatosis, cytoreductive surgery, curative surgery, palliative surgery, hyperthermic intraperitoneal chemotherapy, HIPEC, stage IV cancer, metastatic disease

Clinical experience of afatinib application In non-cell lung cancer of lung. Ii line of therapy (L.M. Kogoniya, E.V. Markarova, G.A. Stashuk, V.E. Shikina)

lung cancer, adenocarcinoma, non-small cell lung cancer, EGFR mutation, chemotherapy, targeted therapy, efficacy, elderly, side effects

Urgent issues of drug therapy and possible solutions (E.V. Karabina)

precision oncology, effectiveness of immunotherapy of malignant tumors, effectiveness of chemotherapy of malignant tumors, recovery of patients with advanced cancer.